2'-fluorothymidine has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickow, B; Dobson, K; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Smith, D; Tehrani, OS; Vaishampayan, UN | 1 |
| Cass, CE; Eriksson, S; Knaus, EE; Kumar, P; Paproski, RJ; Sjuvarsson, EV; Sun, W; Wiebe, LI; Yang, J; Zhou, A | 1 |
1 trial(s) available for 2'-fluorothymidine and Bone Cancer
| Article | Year |
|---|---|
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
Topics: Aged; Arabinofuranosyluracil; Biomarkers, Tumor; Bone Neoplasms; Bone Remodeling; Diphosphonates; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Tomography, X-Ray Computed; Zoledronic Acid | 2017 |
1 other study(ies) available for 2'-fluorothymidine and Bone Cancer
| Article | Year |
|---|---|
Biochemistry and biology of 2'-Fluoro-2'-deoxythymidine (FT), a putative highly selective substrate for thymidine kinase type 2 (TK2).
Topics: Animals; Antineoplastic Agents; Autoradiography; Bone Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Osteosarcoma; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Transgenes | 2012 |